|
ZNF830 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17020000023338E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66789999994843E-06 |
| Normal-vs-Stage2 |
1.415960E-02 |
| Normal-vs-Stage3 |
1.571560E-01 |
| Normal-vs-Stage4 |
7.047700E-02 |
| Stage1-vs-Stage2 |
8.264800E-01 |
| Stage1-vs-Stage3 |
1.639250E-01 |
| Stage1-vs-Stage4 |
8.315000E-01 |
| Stage2-vs-Stage3 |
1.914750E-01 |
| Stage2-vs-Stage4 |
7.197600E-01 |
| Stage3-vs-Stage4 |
4.542600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6981000040015E-08 |
| Normal-vs-AfricanAmerican |
7.735900E-03 |
| Normal-vs-Asian |
1.805370E-01 |
| Caucasian-vs-AfricanAmerican |
8.461500E-02 |
| Caucasian-vs-Asian |
9.241400E-01 |
| AfricanAmerican-vs-Asian |
4.253800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99880000001573E-07 |
| Normal-vs-Female |
9.78849999999643E-05 |
| Male-vs-Female |
8.255000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.029740E-02 |
| Normal-vs-Extreme_Weight |
1.632980E-04 |
| Normal-vs-Obese |
1.165380E-04 |
| Normal-vs-Extreme_Obese |
7.978000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.619400E-01 |
| Normal_Weight-vs-Obese |
5.493400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.053800E-01 |
| Extreme_Weight-vs-Obese |
9.791800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.176200E-01 |
| Obese-vs-Extreme_Obese |
5.558200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.428100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.63780000006497E-07 |
| Normal-vs-Age(61-80Yrs) |
1.570750E-04 |
| Normal-vs-Age(81-100Yrs) |
6.540000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.240400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.583000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.336900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.283190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.646500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.771400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.06429975943456E-10 |
| Normal-VS-Type2 PRCC |
4.151200E-01 |
| Normal-VS-KIRP CIMP |
1.270570E-01 |
| Normal-VS-Unclassified PRCC |
5.998300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.96310000000199E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.332000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.176000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.644170E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.712000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.780400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.103800E-02 |
| Normal-vs-N1 |
7.759800E-03 |
| Normal-vs-N2 |
4.113200E-01 |
| N0-vs-N1 |
1.599830E-01 |
| N0-vs-N2 |
7.838800E-01 |
| N1-vs-N2 |
4.110400E-01 |
|
|
